Ian Eliason

Ian Eliason is a Partner at Zoic Capital, an IP centric life sciences venture fund. Ian is also a Board Member and Investor at ODS Medical Inc, a medical device company specializing in real-time detection of tissue abnormalities. Additionally, Ian serves as an Investor & Advisor at ChromaTan, Probius, BioROSA Technologies, HDT Bio, Optina Diagnostics, Innovein, and Juno Diagnostics, investing in companies aiming to improve human health through innovative solutions. Ian holds a Bachelor of Science degree in Public Health, Finance, and Communications from the University of Minnesota.